There were 1,761 press releases posted in the last 24 hours and 443,003 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image